COLL logo

Collegium Pharmaceutical, Inc. (COLL) Cash from investing

annual CFI:

-$287.76M-$216.95M(-306.37%)
December 31, 2024

Summary

  • As of today (August 16, 2025), COLL annual cash flow from investing activities is -$287.76 million, with the most recent change of -$216.95 million (-306.37%) on December 31, 2024.
  • During the last 3 years, COLL annual CFI has fallen by -$285.81 million (-14702.42%).
  • COLL annual CFI is now -3596887.50% below its all-time high of -$8000.00, reached on December 31, 2014.

Performance

COLL Cash from investing Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherCOLLcash flow metrics

quarterly CFI:

-$2.92M+$6.76M(+69.89%)
June 1, 2025

Summary

  • As of today (August 16, 2025), COLL quarterly cash flow from investing activities is -$2.92 million, with the most recent change of +$6.76 million (+69.89%) on June 1, 2025.
  • Over the past year, COLL quarterly CFI has increased by +$5.99 million (+67.27%).

Performance

COLL quarterly CFI Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherCOLLcash flow metrics

TTM CFI:

-$273.32M+$5.99M(+2.14%)
June 1, 2025

Summary

  • As of today (August 16, 2025), COLL TTM cash flow from investing activities is -$273.32 million, with the most recent change of +$5.99 million (+2.14%) on June 1, 2025.
  • Over the past year, COLL TTM CFI has dropped by -$217.37 million (-388.48%).

Performance

COLL TTM CFI Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherCOLLcash flow metrics

Cash from investing Formula

CFI = Cash Inflows from Investments − Cash Outflows for Investments

COLL Cash from investing Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-306.4%+67.3%-388.5%
3 y3 years-10000.0%-532.3%+52.3%
5 y5 years-4369.7%-30.1%+26.6%

COLL Cash from investing Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year<-9999.0%+49.8%-2479.7%+98.8%<-9999.0%+52.4%
5 y5-year<-9999.0%+49.8%-2479.7%+99.5%<-9999.0%+52.4%
alltimeall time<-9999.0%+49.8%<-9999.0%+99.5%<-9999.0%+52.4%

COLL Cash from investing History

DateAnnualQuarterlyTTM
Jun 2025
-
-$2.92M(-69.9%)
-$273.32M(-2.1%)
Mar 2025
-
-$9.68M(-17.7%)
-$279.31M(-2.9%)
Dec 2024
-$287.76M(+306.4%)
-$11.76M(-95.3%)
-$287.76M(-4.4%)
Sep 2024
-
-$248.96M(+2695.5%)
-$301.09M(+438.1%)
Jun 2024
-
-$8.91M(-50.9%)
-$55.95M(-37.0%)
Mar 2024
-
-$18.13M(-27.8%)
-$88.76M(+25.4%)
Dec 2023
-$70.81M(-87.7%)
-$25.10M(+556.6%)
-$70.81M(+51.8%)
Sep 2023
-
-$3.82M(-90.8%)
-$46.66M(+8.6%)
Jun 2023
-
-$41.72M(>+9900.0%)
-$42.95M(+2441.2%)
Mar 2023
-
-$176.00K(-81.3%)
-$1.69M(-99.7%)
Dec 2022
-$573.69M(>+9900.0%)
-$940.00K(+731.9%)
-$573.69M(+0.1%)
Sep 2022
-
-$113.00K(-75.5%)
-$573.27M(-0.0%)
Jun 2022
-
-$461.00K(-99.9%)
-$573.43M(-0.0%)
Mar 2022
-
-$572.18M(>+9900.0%)
-$573.69M(>+9900.0%)
Dec 2021
-$1.94M(-99.5%)
-$515.00K(+86.6%)
-$1.94M(-33.2%)
Sep 2021
-
-$276.00K(-61.9%)
-$2.91M(-42.2%)
Jun 2021
-
-$725.00K(+69.4%)
-$5.04M(-23.1%)
Mar 2021
-
-$428.00K(-71.1%)
-$6.55M(-98.2%)
Dec 2020
-$373.77M(+5705.7%)
-$1.48M(-38.4%)
-$373.77M(+0.2%)
Sep 2020
-
-$2.40M(+7.2%)
-$373.18M(+0.3%)
Jun 2020
-
-$2.24M(-99.4%)
-$372.13M(+0.4%)
Mar 2020
-
-$367.65M(>+9900.0%)
-$370.76M(+5659.0%)
DateAnnualQuarterlyTTM
Dec 2019
-$6.44M(-73.6%)
-$889.00K(-34.2%)
-$6.44M(-12.1%)
Sep 2019
-
-$1.35M(+54.4%)
-$7.32M(-15.7%)
Jun 2019
-
-$875.00K(-73.7%)
-$8.69M(+1.5%)
Mar 2019
-
-$3.32M(+87.4%)
-$8.56M(-64.9%)
Dec 2018
-$24.35M(+2360.0%)
-$1.77M(-34.7%)
-$24.35M(+7.0%)
Sep 2018
-
-$2.72M(+263.7%)
-$22.75M(+11.7%)
Jun 2018
-
-$747.00K(-96.1%)
-$20.38M(+1.5%)
Mar 2018
-
-$19.12M(>+9900.0%)
-$20.08M(+1928.1%)
Dec 2017
-$990.00K(-66.7%)
-$172.00K(-49.4%)
-$990.00K(-14.6%)
Sep 2017
-
-$340.00K(-24.3%)
-$1.16M(+24.6%)
Jun 2017
-
-$449.00K(+1448.3%)
-$930.00K(-69.1%)
Mar 2017
-
-$29.00K(-91.5%)
-$3.01M(+1.0%)
Dec 2016
-$2.98M(+722.4%)
-$341.00K(+207.2%)
-$2.98M(+5.5%)
Sep 2016
-
-$111.00K(-95.6%)
-$2.82M(-1.4%)
Jun 2016
-
-$2.52M(+1250.3%)
-$2.86M(+691.2%)
Dec 2015
-$362.00K(+4425.0%)
-$187.00K(+23.0%)
-$362.00K(+97.8%)
Sep 2015
-
-$152.00K(+560.9%)
-$183.00K(+490.3%)
Jun 2015
-
-$23.00K(+187.5%)
-$31.00K(+287.5%)
Dec 2014
-$8000.00(-96.1%)
-$8000.00(<-9900.0%)
-$8000.00(<-9900.0%)
Jun 2014
-
$0.00(0.0%)
$0.00(0.0%)
Mar 2014
-
$0.00
$0.00
Dec 2013
-$206.00K
-
-

FAQ

  • What is Collegium Pharmaceutical, Inc. annual cash flow from investing activities?
  • What is the all time high annual CFI for Collegium Pharmaceutical, Inc.?
  • What is Collegium Pharmaceutical, Inc. annual CFI year-on-year change?
  • What is Collegium Pharmaceutical, Inc. quarterly cash flow from investing activities?
  • What is the all time high quarterly CFI for Collegium Pharmaceutical, Inc.?
  • What is Collegium Pharmaceutical, Inc. quarterly CFI year-on-year change?
  • What is Collegium Pharmaceutical, Inc. TTM cash flow from investing activities?
  • What is the all time high TTM CFI for Collegium Pharmaceutical, Inc.?
  • What is Collegium Pharmaceutical, Inc. TTM CFI year-on-year change?

What is Collegium Pharmaceutical, Inc. annual cash flow from investing activities?

The current annual CFI of COLL is -$287.76M

What is the all time high annual CFI for Collegium Pharmaceutical, Inc.?

Collegium Pharmaceutical, Inc. all-time high annual cash flow from investing activities is -$8000.00

What is Collegium Pharmaceutical, Inc. annual CFI year-on-year change?

Over the past year, COLL annual cash flow from investing activities has changed by -$216.95M (-306.37%)

What is Collegium Pharmaceutical, Inc. quarterly cash flow from investing activities?

The current quarterly CFI of COLL is -$2.92M

What is the all time high quarterly CFI for Collegium Pharmaceutical, Inc.?

Collegium Pharmaceutical, Inc. all-time high quarterly cash flow from investing activities is $0.00

What is Collegium Pharmaceutical, Inc. quarterly CFI year-on-year change?

Over the past year, COLL quarterly cash flow from investing activities has changed by +$5.99M (+67.27%)

What is Collegium Pharmaceutical, Inc. TTM cash flow from investing activities?

The current TTM CFI of COLL is -$273.32M

What is the all time high TTM CFI for Collegium Pharmaceutical, Inc.?

Collegium Pharmaceutical, Inc. all-time high TTM cash flow from investing activities is $0.00

What is Collegium Pharmaceutical, Inc. TTM CFI year-on-year change?

Over the past year, COLL TTM cash flow from investing activities has changed by -$217.37M (-388.48%)
On this page